Markers such as CD11c and CD40, which are associated with antigen-presenting cells, were enhanced in stage III NPC, and the expression of immune-checkpoint markers PD-L1 and IDO1, and other proteins such as GZMB and SMA, were highest in stage IVA compared with the rest. Here, CD40 is linked to nasopharyngeal carcinoma.